Nephrol Dial Transplant (2002) 17: 28-31
© 2002 European Renal Association-European Dialysis and Transplant Association
The malnutrition, inflammation, and atherosclerosis (MIA) syndrome – the heart of the matter
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden
Abstract
The majority of patients starting dialysis already have signs of advanced atherosclerosis, and the risk factors for cardiovascular morbidity and mortality seen in patients with end-stage renal disease (ESRD) develop with the disease progression. Therefore, the predialysis period is the ideal time to start therapeutic interventions. Traditional risk factors alone may not adequately predict cardiovascular disease (CVD) outcome in patients with ESRD. Inflammation has been identified as playing a key role in atherosclerotic CVD. Pro-inflammatory cytokines are pivotal to the inflammation that is associated with malnutrition and atherosclerosis in ESRD. Malnutrition may worsen patient outcome by aggravating existing inflammation and heart failure, accelerating atherosclerosis and increasing susceptibility to infection. Atherosclerosis is itself a major risk factor for CVD mortality. Moreover, inflammation is associated with congestive heart failure. Strong associations between malnutrition, inflammation and atherosclerosis in this patient population suggest the presence of a syndrome we have called malnutrition, inflammation, and atherosclerosis (MIA), which is associated with an exceptionally high mortality rate.
Keywords: atherosclerosis; chronic kidney disease; congestive heart failure; inflammation; malnutrition; MIA syndrome
Notes
Correspondence and offprint requests to: Dr P. Stenvinkel, Department of Renal Medicine K56, Huddinge University Hospital, S-14 186 Stockholm, Sweden. Email: peter.stenvinkel{at}klinvet.ki.se
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Rao, L. Li, H. Tighiouart, B. L. Jaber, B. J. G. Pereira, V. S. Balakrishnan, and the HEMO Study Group Plasma adiponectin levels and clinical outcomes among haemodialysis patients Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2619 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M.C. Brunini, A. C. Mendes-Ribeiro, J. C. Ellory, and G. E. Mann Platelet nitric oxide synthesis in uremia and malnutrition: A role for L-arginine supplementation in vascular protection? Cardiovasc Res, January 15, 2007; 73(2): 359 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, J. Coresh, J. A. Eustace, J. C. Longenecker, B. Jaar, N. E. Fink, R. P. Tracy, N. R. Powe, and M. J. Klag Association Between Cholesterol Level and Mortality in Dialysis Patients: Role of Inflammation and Malnutrition JAMA, January 28, 2004; 291(4): 451 - 459. [Abstract] [Full Text] [PDF]
|
|